The origins and time of appearance of focal testicular dysgenesis in an animal model of testicular dysgenesis syndrome: Evidence for delayed testis development?

International Journal of Andrology

Volumn 31, Issue 2, 2008, Pages 103-111

  Hutchison, Gary R ^a   Sharpe, Richard M ^a   Mahood, I Kim ^a   Jobling, Matt ^a   Walker, Marion ^a   McKinnell, Chris ^a   Mason, J Ian ^a   Scott, Hayley M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Di(n butyl) phthalate; Dysgenetic areas; Fetal Leydig cell aggregation; Fetal testis; Intratublar Leydig cells; Seminiferous cords; Sertoli cells

Indexed keywords

PHTHALIC ACID DIBUTYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL AGGREGATION; CELL DIFFERENTIATION; CELL MATURATION; CELL SIZE; CELL SPECIFICITY; CONFERENCE PAPER; CONTROLLED STUDY; DEL CASTILLO SYNDROME; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEMINIFEROUS TUBULE; SERTOLI CELL; TESTIS DEVELOPMENT; TESTIS DISEASE;

EID: 40349096305     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2007.00816.x     Document Type: Conference Paper

References (12)

1. Barlow, N. J. & Foster, P. M. D. (2003) Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to Di(n ‐butyl) phthalate. Toxicologic Pathology 31, 397–410.
2. Ferrara, D., Hallmark, N., Scott, H. M., Brown, R., McKinnell, C., Mahood, I. K. & Sharpe, R. M. (2006) Acute and long‐term effects of in utero exposure of rats to Di(n ‐butyl) phthalate on testicular germ cell development and proliferation. Endocrinology 14, 5352–5362.
3. Fisher, J. S., Macpherson, S., Marchetti, N. & Sharpe, R. M. (2003) Human ‘testicular dysgenesis syndrome’: a possible model using in‐utero exposure of the rat to dibutyl phthalate. Human Reproduction 18, 1–13.
4. Hoei‐Hansen, C. E., Holm, M., Rajpert‐De Meyts, E. & Skakkebaek, N. E. (2003) Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. Journal of Pathology 200, 370–374.
5. Jarfelt, K., Dalgaard, M., Hass, U., Borch, J., Jacobsen, H. & Ladefoged, O. (2005) Antinadrogenic effects in male rats perinatally exposed to a mixture of Di(2‐ethylhexyl) phthalate and di(2‐ethylhexyl) adipate. Reproductive Toxicology 19, 505–515.
6. Mahood, I. K., Hallmark, N., McKinnell, C., Walker, M., Fisher, J. S. & Sharpe, R. M. (2005) Abnormal Leydig Cell aggregation in the fetal testis of rats exposed to Di(n ‐Butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology 146, 613–623.
7. Mahood, I. K., McKinnell, C., Walker, M., Hallmark, N., Scott, H., Fisher, J. S. et al. (2006) Cellular origins of testicular dysgenesis in rats exposed in utero to Di(n ‐butyl) phthalate. International Journal of Andrology 29, 148–154.
8. Mylchreest, E., Wallace, D. G., Cattley, R. C. & Foster, P. M. D. (2000) Dose‐dependent alterations in androgen‐regulated male reproductive development in rats exposed to Di(n ‐butyl) phthalate during late gestation. Toxicological Sciences 55, 143–151.
9. Scott, H. M., Hutchison, G. R., Mahood, I. K., Hallmark, N., Welsh, M., De Gendt, K., Verhoeven, G., O’Shaughnessy, P. & Sharpe, R. M. (2007) Role of androgens in fetal testis development and dysgenesis. Endocrinology 148, 2027–2036.
10. Sharpe, R. M. (2006) Pathways of endocrine disruption during male sexual differentiation and masculinization. Best Practice in Research in Clinical Endocrinology and Metabolism 20, 91–110.
11. Sharpe, R. M. & Skakkebaek, N. E. (2003) Male reproductive disorders and the role of endocrine disruption: advances in understanding and identification of areas for future research. Pure and Applied Chemistry 75, 2023–2038.
12. Skakkebaek, N. E., Rajpert‐De Meyts, E. & Main, K. M. (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction 16, 972–978.